Argyrios Tzouvelekis, Ph.D.

Home
Research & Reports
About Our Research
Previously Funded Researchers
Argyrios Tzouvelekis, Ph.D.

Research Project:
Enzyme Could Play Key Role in Idiopathic Pulmonary Fibrosis

Grant Awarded:

Senior Research Training Fellowship

Research Topic:

basic biologic mechanisms

Research Disease:

pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a devastating chronic lung disease in which lung tissue becomes scarred over time in response to unknown injuries. This leads to shortness of breath and dry cough that gradually progresses, culminating in death in 3-5 years. The IPF lung is characterized by increases in cells in the lung called fibroblasts. We have discovered an enzyme called SHP-2 is decreased in the lung fibroblasts of patients with IPF. We will study whether reduced levels of SHP-2 from the lungs of patients with IPF render them susceptible to disease development, and whether restoring its levels in a mouse model of lung fibrosis may exert a therapeutic role.

Page last updated: April 30, 2024

Join the Patient & Caregiver Network

How to Help People Quit

10 Tips to Protect Yourself from Unhealthy Air

State of the Air Key Findings

Become an Advocate

Register for a LUNG FORCE Walk

Double Your Gift

Argyrios Tzouvelekis, Ph.D.

2X Your Lifesaving Impact

Make a Donation

Become a Lung Health Insider

Select Your Location

Change Language

Lung HelpLine

1-800-LUNG-USA